| | Group : Standards; Chiral Molecules; Molecular Biology; Am Group : Standards; Chiral Molecules; Nicotine Derivatives Group : Standards; Enzyme Activators and Inhibitors; Anti- Group : Standards; Enzyme Activators and Inhibitors; Dyes; Group : Standards; Enzyme Activators and Inhibitors; Other Group : Standards; Enzyme Activators and Inhibitors; Stimu Group : Standards; Ephedrine; Phenethylamines/Amphetamine Group : Standards; Fluorescent Reagents; Carbohydrates an Group : Standards; Fluorescent Reagents; Pharmaceutical/AP Group : Standards; Fluorescent Reagents; Vitamin Derivati Group : Standards; Isotopic Labeled Analogues; Carbohydra Group : Standards; Isotopic Labeled Analogues; Food Mutage Group : Standards; Isotopic Labeled Analogues; Others; Pha Group : Standards; Isotopic Labeled Analogues; Pharmaceuti (4R,4AS,6S,6AR,11BS)-6-CARBOXY-3-(CYCLOPROPYLMETHYL)-1,2,3,4,4A,5,6,6A-OCTAHYDRO-4A,6,8-TRIHYDROXY-3-METHYL-4,11-METHANOBENZOFURO[3',2':2,3]CYCLOPENTA[1,2-C]PYRIDINIUM BROMIDE-D3 CAS:N/A Formula: C21 D3 H23 N O6 . Br TRC-C176952-25MG C176952 471.36 (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione-d6(Doxorubicin Impurity) CAS:N/A Formula: C29H28D6BrNO11 TRC-A630407-5MG A630407 658.52 |